Literature DB >> 21042282

Disruption of NAD(P)H:quinone oxidoreductase 1 gene in mice leads to 20S proteasomal degradation of p63 resulting in thinning of epithelium and chemical-induced skin cancer.

B A Patrick1, X Gong, A K Jaiswal.   

Abstract

NAD(P)H:quinone oxidoreductase 1 (NQO1) is a cytosolic enzyme that protects cells against chemical and radiation-induced oxidative stress and skin cancer. Disruption of NQO1 gene in mice showed thinning of skin epithelium and loss of cytokeratin 14, an early marker of skin differentiation. Immunohistochemistry and western analysis demonstrated downregulation of p63 in NQO1-/- mouse skin, as compared with wild-type (WT) mouse. Further analysis including modulation of NQO1 expression revealed a direct correlation between the levels of NQO1 and p63 in skin-derived keratinocytes and dermal fibroblasts. Modulation of proteasomal activity revealed that p63 is degraded by 20S proteasome and that this degradation is significantly rescued by NQO1. Coimmunoprecipitation studies showed that NQO1 interacts directly with p63 but not 20S to protect against this degradation. In addition, benzo[a]pyrene treatment led to induction of NQO1 and stabilization of p63 in WT but not in NQO1-/- mouse skin and keratinocytes. These data suggest that NQO1 controls stabilization of p63 and progression towards keratinocyte differentiation leading to normal skin development and presumably skin carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21042282      PMCID: PMC3307144          DOI: 10.1038/onc.2010.491

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  33 in total

Review 1.  Structure and function in the p53 family.

Authors:  C H Arrowsmith
Journal:  Cell Death Differ       Date:  1999-12       Impact factor: 15.828

Review 2.  NAD(P)H:quinone oxidoreductase 1 (NQO1): chemoprotection, bioactivation, gene regulation and genetic polymorphisms.

Authors:  D Ross; J K Kepa; S L Winski; H D Beall; A Anwar; D Siegel
Journal:  Chem Biol Interact       Date:  2000-12-01       Impact factor: 5.192

3.  NAD(P)H:quinone oxidoreductase 1 deficiency and increased susceptibility to 7,12-dimethylbenz[a]-anthracene-induced carcinogenesis in mouse skin.

Authors:  D J Long; R L Waikel; X J Wang; D R Roop; A K Jaiswal
Journal:  J Natl Cancer Inst       Date:  2001-08-01       Impact factor: 13.506

4.  NAD(P)H:quinone oxidoreductase 1 deficiency increases susceptibility to benzo(a)pyrene-induced mouse skin carcinogenesis.

Authors:  D J Long; R L Waikel; X J Wang; L Perlaky; D R Roop; A K Jaiswal
Journal:  Cancer Res       Date:  2000-11-01       Impact factor: 12.701

Review 5.  Structure-function studies of DT-diaphorase (NQO1) and NRH: quinone oxidoreductase (NQO2).

Authors:  S Chen; K Wu; R Knox
Journal:  Free Radic Biol Med       Date:  2000-08       Impact factor: 7.376

Review 6.  Nrf2 signaling in coordinated activation of antioxidant gene expression.

Authors:  Anil K Jaiswal
Journal:  Free Radic Biol Med       Date:  2004-05-15       Impact factor: 7.376

Review 7.  p63 and p73: roles in development and tumor formation.

Authors:  Ute M Moll; Neda Slade
Journal:  Mol Cancer Res       Date:  2004-07       Impact factor: 5.852

8.  Disruption of dihydronicotinamide riboside:quinone oxidoreductase 2 (NQO2) leads to myeloid hyperplasia of bone marrow and decreased sensitivity to menadione toxicity.

Authors:  Delwin J Long; Karim Iskander; Amos Gaikwad; Meral Arin; Dennis R Roop; Richard Knox; Roberto Barrios; Anil K Jaiswal
Journal:  J Biol Chem       Date:  2002-09-25       Impact factor: 5.157

9.  Inactivation of the quinone oxidoreductases NQO1 and NQO2 strongly elevates the incidence and multiplicity of chemically induced skin tumors.

Authors:  Jun Shen; Roberto J Barrios; Anil K Jaiswal
Journal:  Cancer Res       Date:  2010-01-26       Impact factor: 12.701

10.  Deficiency of NRH:quinone oxidoreductase 2 increases susceptibility to 7,12-dimethylbenz(a)anthracene and benzo(a)pyrene-induced skin carcinogenesis.

Authors:  Karim Iskander; Marilene Paquet; Cory Brayton; Anil K Jaiswal
Journal:  Cancer Res       Date:  2004-09-01       Impact factor: 12.701

View more
  16 in total

1.  Induction of NAD(P)H-quinone oxidoreductase 1 by antioxidants in female ACI rats is associated with decrease in oxidative DNA damage and inhibition of estrogen-induced breast cancer.

Authors:  Bhupendra Singh; Nimee K Bhat; Hari K Bhat
Journal:  Carcinogenesis       Date:  2011-11-09       Impact factor: 4.944

2.  The protein level of PGC-1α, a key metabolic regulator, is controlled by NADH-NQO1.

Authors:  Yaarit Adamovich; Amir Shlomai; Peter Tsvetkov; Kfir B Umansky; Nina Reuven; Jennifer L Estall; Bruce M Spiegelman; Yosef Shaul
Journal:  Mol Cell Biol       Date:  2013-05-06       Impact factor: 4.272

3.  Control of stability of cyclin D1 by quinone reductase 2 in CWR22Rv1 prostate cancer cells.

Authors:  Tze-chen Hsieh; Ching-Jen Yang; Chia-Yi Lin; Yong-Syu Lee; Joseph M Wu
Journal:  Carcinogenesis       Date:  2012-01-19       Impact factor: 4.944

4.  Topical hesperidin improves epidermal permeability barrier function and epidermal differentiation in normal murine skin.

Authors:  Maihua Hou; Mona Man; Wenyan Man; Wenyuan Zhu; Melanie Hupe; Kyungho Park; Debra Crumrine; Peter M Elias; Mao-Qiang Man
Journal:  Exp Dermatol       Date:  2012-05       Impact factor: 3.960

5.  miR-205 regulates basement membrane deposition in human prostate: implications for cancer development.

Authors:  P Gandellini; V Profumo; A Casamichele; N Fenderico; S Borrelli; G Petrovich; G Santilli; M Callari; M Colecchia; S Pozzi; M De Cesare; M Folini; R Valdagni; R Mantovani; N Zaffaroni
Journal:  Cell Death Differ       Date:  2012-05-04       Impact factor: 15.828

6.  NAD(P)H:quinone oxidoreductase 1 protects bladder epithelium against painful bladder syndrome in mice.

Authors:  Brad A Patrick; Amitava Das; Anil K Jaiswal
Journal:  Free Radic Biol Med       Date:  2012-08-31       Impact factor: 7.376

7.  NRH:quinone oxidoreductase 2 (NQO2) protein competes with the 20 S proteasome to stabilize transcription factor CCAAT enhancer-binding protein α (C/EBPα), leading to protection against γ radiation-induced myeloproliferative disease.

Authors:  Junkang Xu; Brad Allen Patrick; Anil K Jaiswal
Journal:  J Biol Chem       Date:  2013-10-19       Impact factor: 5.157

8.  NAD(P)H:quinone oxidoreductase 1 (NQO1) competes with 20S proteasome for binding with C/EBPα leading to its stabilization and protection against radiation-induced myeloproliferative disease.

Authors:  Junkang Xu; Anil K Jaiswal
Journal:  J Biol Chem       Date:  2012-10-18       Impact factor: 5.157

9.  NQO1 suppresses NF-κB-p300 interaction to regulate inflammatory mediators associated with prostate tumorigenesis.

Authors:  Dinesh Thapa; Peng Meng; Roble G Bedolla; Robert L Reddick; Addanki P Kumar; Rita Ghosh
Journal:  Cancer Res       Date:  2014-08-14       Impact factor: 12.701

10.  NAD(P)H:quinone oxidoreductase 1 (NQO1) localizes to the mitotic spindle in human cells.

Authors:  David Siegel; Jadwiga K Kepa; David Ross
Journal:  PLoS One       Date:  2012-09-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.